Release a U.S.-bound bulk tea shipment only when four separate controls agree: the importer has an applicable FSVP, the foreign facility and entry identities are accurate, Prior Notice is ready, and the physical lot matches the approved food-safety evidence. A supplier questionnaire, audit certificate or certificate of analysis can contribute evidence, but none replaces the U.S. importer's own documented risk decisions.
Separate four files that buyers often mix together
The Food and Drug Administration does not approve ordinary food importers, individual foods, labels or shipments before import. The responsible parties must instead meet the requirements that apply to the product and transaction. For bulk tea, keep these files connected but distinct:
- FSVP file: the importer evaluates the food's hazards and supplier performance, approves the foreign supplier, selects verification activities and records corrective actions.
- Facility-registration file: the relevant foreign establishment confirms whether it must register and maintains its registration. FDA says registration data are confidential, so a public search is not a reliable verification route.
- Prior Notice and entry file: the filer transmits the accurate food, manufacturer, shipper, country, arrival, quantity and transport data required for the shipment.
- Commercial release file: the parties control the purchase specification, representative sample, lot COA, packing, labels, traceability and shipping documents.
These layers do different jobs. A legal requirement is binding within its scope; 21 CFR Part 1 contains the FSVP, registration and Prior Notice rules. FDA's 2023 final FSVP guidance explains the agency's current thinking but is nonbinding. A trade reference such as a grade name or audit scheme supports communication but is not a U.S. release decision. A buyer specification sets measurable product and evidence requirements. A contract requirement allocates who supplies, reviews and corrects each item; it cannot transfer the importer's statutory responsibility.
Build an eight-part release dossier
| Control record | Minimum decision content | Release question |
|---|---|---|
| Importer and scope | FSVP importer identity; food/supplier pair; exemption or modified-requirement rationale if claimed; qualified individual | Who owns the regulatory decision for this food? |
| Written hazard analysis | Biological, chemical and physical hazards; intended use; probability, severity and entity controlling each hazard | Which hazards require a control, and why? |
| Supplier evaluation | Food risk, control responsibility, supplier procedures, compliance history, test/audit history and transport/storage factors | Is this supplier approvable for this specific tea? |
| Verification plan | Activity, frequency, responsible qualified person, records required, review rule and corrective-action trigger | Does testing, auditing or record review match the identified risk? |
| Facility identity | Exact legal name, address, manufacturing/processing/packing role, registration status where required and U.S. agent coordination | Will the declared facility match FDA's internal record? |
| Lot release | Approved specification and sample, representative sampling, test methods/results, pack/label check, quantity and lot genealogy | Is the shipped lot the one the evidence describes? |
| Prior Notice/entry data | FDA product identity, manufacturer, shipper, production/shipping countries, quantity, arrival and transport identifiers | Do regulatory data match the documents and cargo? |
| Exception record | Hold reason, investigation, disposition, corrective action, reapproval and record owner | Can a discrepancy be resolved before entry or release? |
Use an eight-step pre-shipment method
- Name the correct FSVP importer. Under 21 CFR 1.500, this is generally the U.S. owner or consignee at entry, or, if none exists then, the U.S. agent or representative of the foreign owner or consignee who has signed consent. FDA notes that the FSVP importer may differ from the customs importer of record. Freeze the name, email and acceptable unique facility identifier supplied for each entry line before the broker files.
- Decide the rule path before collecting documents. Check whether standard FSVP, modified requirements, an exemption or another applicable pathway governs the exact importer, food and use. Do not label a company “very small” from an unsupported statement. A June 2026 FDA warning letter involving imported green tea illustrates the evidence problem: FDA said eligibility support and a written FSVP were not adequately documented. An enforcement letter is case-specific, not a universal finding about tea or any other company.
- Write the hazard analysis for the actual tea. Section 1.504 requires a written analysis even when it concludes that no hazard requires a control. Consider biological, chemical and physical hazards, including pesticide residues, natural toxins, unapproved additives, allergens where applicable, economically motivated hazards and foreign material. Evaluate intended use, processing, packaging, storage and transport. Do not paste a generic “dry tea is low risk” sentence over a product that may be consumed without a further kill step or used as an ingredient.
- Approve the supplier through documented evaluation. Connect the hazard analysis to the entity controlling each hazard, the supplier's food-safety procedures, relevant FDA compliance information, testing and audit history, corrective-action performance, and storage/transport factors. Use the site's Chinese tea factory verification method as evidence gathering, then let a qualified individual make and document the U.S. regulatory evaluation.
- Select verification activities from risk. Possible activities include an onsite audit, representative sampling and testing, review of supplier food-safety records or another appropriate activity. Section 1.506 requires documented details and review; a supplier-issued COA is not self-approving. The record for testing should identify the tea and lot, sample count, tests and methods, dates, results, laboratory, corrective actions and qualified person. Check the limits of a tea COA and select an appropriately scoped laboratory.
- Reconcile the establishment and food identity. Section 1.225 generally requires domestic or foreign facilities manufacturing, processing, packing or holding food for U.S. consumption to register unless an exemption applies. Confirm the exact facility role and legal identity directly; never treat a screenshot, consultant certificate or registration number as FDA endorsement. Match the manufacturer and shipper names across the commercial invoice, packing list, bill of lading, lot records and broker master data.
- Prepare Prior Notice from the final shipment facts. Prior Notice is a separate pre-arrival filing. For a processed food, required information can include the FDA product code, common or market name, quantity by packaging level, manufacturer identity, FDA country of production, shipper, country shipped from, arrival details, importer, owner, ultimate consignee, mode, carrier and transport document data. Treat the regulation and current filing system as controlling; use a pre-alert worksheet so a changed voyage, quantity, manufacturer or shipper is corrected everywhere before transmission.
- Run a final three-way release. First, the qualified FSVP reviewer confirms supplier approval and current verification evidence. Second, quality confirms the shipped lot meets the purchase specification, testing plan, packing and traceability controls. Third, logistics confirms Prior Notice and entry data against final documents. Use pass only when all three agree; hold/clarify for a resolvable gap; and fail/escalate when the supplier, product, lot or required control contradicts the approved file.
Common buyer mistakes
- Assuming the customs importer of record is automatically the FSVP importer.
- Buying an “FSVP certificate” instead of maintaining a food- and supplier-specific program.
- Claiming an exemption or modified status without evidence and a written scope decision.
- Using a facility registration as FDA approval of the company, food or shipment.
- Copying a generic hazard analysis that does not address the tea's form and intended use.
- Collecting audits and COAs without documenting who reviewed them and what decision followed.
- Testing a convenient sample that cannot be linked to the packed lot.
- Letting broker master data drift from the supplier's current legal name and facility.
- Treating Prior Notice acceptance as proof that FSVP and product compliance are complete.
- Shipping while an importer, manufacturer, lot or transport discrepancy remains unresolved.
Practical conclusion
The usable sequence is scope - importer - hazard analysis - supplier approval - risk-based verification - facility match - lot release - Prior Notice/entry reconciliation. Keep one controlled index showing the owner, version, review date and decision for each record. The foreign supplier can provide accurate facility, process, testing and lot evidence; the U.S. importer and its qualified advisers must determine the applicable law and make the FSVP decision. For a proposed bulk order, send the tea type, specification, destination, pack, volume and required document list early enough to close gaps before booking.
Sources checked 6 September 2026: the current 21 CFR Part 1, Subpart L on Foreign Supplier Verification Programs, especially §§ 1.500 and 1.502-1.509; Subpart H on food-facility registration; and Subpart I on Prior Notice. Title 21 eCFR was current through 3 September 2026 and last amended 31 August 2026 on the check date. Also checked FDA's January 2023 final, nonbinding FSVP guidance, current human-food import overview, and the case-specific 15 June 2026 FSVP warning letter. Check the live regulation, product facts and qualified U.S. advice for each shipment.
